Literature DB >> 12592577

Uptake of antineoplastic agents in pharmacy personnel. Part II: study of work-related risk factors.

Claudia Schreiber1, Katja Radon, Angelika Pethran, Rudolf Schierl, Karlheinz Hauff, Carl-Heinz Grimm, Karl-Siegfried Boos, Dennis Nowak.   

Abstract

OBJECTIVES: This study aimed to find working conditions related to internal exposure of substances handled in centralised cytostatic drug preparation units in hospitals. Recommendations to avoid this uptake should be deduced from the results.
METHOD: In a longitudinal study over 3 years, 87 pharmacy technicians and pharmacists of 14 different hospitals in Germany provided 24-h urine samples separately up to three times (three sampling cycles: cycles 1-3) at the end of a working week. Additional samples were taken after 2 days and after at least 3 weeks of absence. Cyclophosphamide and ifosfamide, doxo-, dauno- epi-, and idarubicin, and platinum deriving from cis- and carboplatin were determined in urine samples by gas chromatography/mass spectrometry, liquid chromatography (HPLC) and voltammetry. The following working conditions were assessed by questionnaire: working tasks, different ways that the workbenches were run, cleaning conditions, waste disposal, number of preparations, amount of substances handled, and use of gloves (material, thickness and changing interval).
RESULTS: Two-thirds of the subjects showed at least one positive result with regard to all three cycles (56 of initially 87 subjects). Employees who only pass material that is needed for processing are affected, just as are those who only prepare administrations and those alternating in both functions (25% vs. 24.1% vs. 50.6%, respectively). The storage of waste in containers that could be opened to add waste tends to increase the risk of internal exposure of ifosfamide and cyclophosphamide (odds ratios (95% confidence interval): 0.08 (0.013-0.5) and 0.19 (0.03-1.12), respectively). The amount handled and number of preparations of cyclophosphamide for "manufacturers" were associated with internal exposure of cyclophosphamide (28.04 (1.75-448.74) and 1.22 (1.03-1.44), respectively). The total number of preparations handled by assistants seemed to increase the risk of intake of any of the substances under study [1.04 (1.00-1.08)].
CONCLUSION: Since employees who pass materials are affected in the same way as those who prepare administrations, both have to be included in reviewing protective measures. Further studies must be carried out to verify the generated hypotheses of factors related to internal exposure found in this study.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12592577     DOI: 10.1007/s00420-002-0385-6

Source DB:  PubMed          Journal:  Int Arch Occup Environ Health        ISSN: 0340-0131            Impact factor:   3.015


  10 in total

1.  Hazardous drug residue on exterior vial surfaces: evaluation of a commercial manufacturing process.

Authors:  Luci A Power; Paul J M Sessink; Kathy Gesy; Flay Charbonneau
Journal:  Hosp Pharm       Date:  2014-04

2.  Reduction in surface contamination with antineoplastic drugs in 22 hospital pharmacies in the US following implementation of a closed-system drug transfer device.

Authors:  Paul J M Sessink; Thomas H Connor; James A Jorgenson; Timothy G Tyler
Journal:  J Oncol Pharm Pract       Date:  2010-02-15       Impact factor: 1.809

Review 3.  Environmental monitoring by surface sampling for cytotoxics: a review.

Authors:  Petit Marie; Curti Christophe; Roche Manon; Montana Marc; Bornet Charleric; Vanelle Patrice
Journal:  Environ Monit Assess       Date:  2017-01-06       Impact factor: 2.513

4.  Reduction in Surface Contamination With Cyclophosphamide in 30 US Hospital Pharmacies Following Implementation of a Closed-System Drug Transfer Device.

Authors:  Paul J M Sessink; Jason Trahan; Joseph W Coyne
Journal:  Hosp Pharm       Date:  2013-03

5.  Impact of closed-system drug transfer device on exposure of environment and healthcare provider to cyclophosphamide in Japanese hospital.

Authors:  Tomohiro Miyake; Takuya Iwamoto; Manabu Tanimura; Masahiro Okuda
Journal:  Springerplus       Date:  2013-06-21

6.  Monitoring of platinum surface contamination in seven Dutch hospital pharmacies using inductively coupled plasma mass spectrometry.

Authors:  E E M Brouwers; A D R Huitema; E N Bakker; J W Douma; K J M Schimmel; G van Weringh; P J de Wolf; J H M Schellens; J H Beijnen
Journal:  Int Arch Occup Environ Health       Date:  2007-03-22       Impact factor: 3.015

7.  Towards safety of oral anti-cancer agents, the need to educate our pharmacists.

Authors:  Sanaa Saeed Mekdad; Adher Dhaya AlSayed
Journal:  Saudi Pharm J       Date:  2015-06-23       Impact factor: 4.330

8.  Handling of antineoplastic drugs: a health concern among health care workers.

Authors:  Stephanie Damasceno Rocha; Andre Nascimento Honorato Gomes; Paulo Ricardo Gazzola Zen; Claudia Giuliano Bica
Journal:  Rev Bras Med Trab       Date:  2021-03-03

Review 9.  Interactions between nanosized materials and the brain.

Authors:  M Simkó; Mats-Olof Mattsson
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

10.  Assessment of Nurse's Safe Behavior Towards Chemotherapy Management.

Authors:  Maria Koulounti; Zoe Roupa; Charalambos Charalambous; Maria Noula
Journal:  Mater Sociomed       Date:  2019-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.